Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Genetic analysis of determinants for spike glycoprotein assembly into murine coronavirus virions: distinct roles for charge-rich and cysteine-rich regions of the endodomain.

Identifieur interne : 002B97 ( PubMed/Corpus ); précédent : 002B96; suivant : 002B98

Genetic analysis of determinants for spike glycoprotein assembly into murine coronavirus virions: distinct roles for charge-rich and cysteine-rich regions of the endodomain.

Auteurs : Rong Ye ; Cynthia Montalto-Morrison ; Paul S. Masters

Source :

RBID : pubmed:15331724

English descriptors

Abstract

The coronavirus spike protein (S) forms the distinctive virion surface structures that are characteristic of this viral family, appearing in negatively stained electron microscopy as stems capped with spherical bulbs. These structures are essential for the initiation of infection through attachment of the virus to cellular receptors followed by fusion to host cell membranes. The S protein can also mediate the formation of syncytia in infected cells. The S protein is a type I transmembrane protein that is very large compared to other viral fusion proteins, and all except a short carboxy-terminal segment of the S molecule constitutes the ectodomain. For the prototype coronavirus mouse hepatitis virus (MHV), it has previously been established that S protein assembly into virions is specified by the carboxy-terminal segment, which comprises the transmembrane domain and the endodomain. We have genetically dissected these domains in the MHV S protein to localize the determinants of S incorporation into virions. Our results establish that assembly competence maps to the endodomain of S, which was shown to be sufficient to target a heterologous integral membrane protein for incorporation into MHV virions. In particular, mutational analysis indicated a major role for the charge-rich carboxy-terminal region of the endodomain. Additionally, we found that the adjacent cysteine-rich region of the endodomain is critical for fusion of infected cells, confirming results previously obtained with S protein expression systems.

DOI: 10.1128/JVI.78.18.9904-9917.2004
PubMed: 15331724

Links to Exploration step

pubmed:15331724

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Genetic analysis of determinants for spike glycoprotein assembly into murine coronavirus virions: distinct roles for charge-rich and cysteine-rich regions of the endodomain.</title>
<author>
<name sortKey="Ye, Rong" sort="Ye, Rong" uniqKey="Ye R" first="Rong" last="Ye">Rong Ye</name>
<affiliation>
<nlm:affiliation>Wadsworth Center, New York State Department of Health, New Scotland Ave., P.O. Box 22002, Albany, NY 12201-2002, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Montalto Morrison, Cynthia" sort="Montalto Morrison, Cynthia" uniqKey="Montalto Morrison C" first="Cynthia" last="Montalto-Morrison">Cynthia Montalto-Morrison</name>
</author>
<author>
<name sortKey="Masters, Paul S" sort="Masters, Paul S" uniqKey="Masters P" first="Paul S" last="Masters">Paul S. Masters</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15331724</idno>
<idno type="pmid">15331724</idno>
<idno type="doi">10.1128/JVI.78.18.9904-9917.2004</idno>
<idno type="wicri:Area/PubMed/Corpus">002B97</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002B97</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Genetic analysis of determinants for spike glycoprotein assembly into murine coronavirus virions: distinct roles for charge-rich and cysteine-rich regions of the endodomain.</title>
<author>
<name sortKey="Ye, Rong" sort="Ye, Rong" uniqKey="Ye R" first="Rong" last="Ye">Rong Ye</name>
<affiliation>
<nlm:affiliation>Wadsworth Center, New York State Department of Health, New Scotland Ave., P.O. Box 22002, Albany, NY 12201-2002, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Montalto Morrison, Cynthia" sort="Montalto Morrison, Cynthia" uniqKey="Montalto Morrison C" first="Cynthia" last="Montalto-Morrison">Cynthia Montalto-Morrison</name>
</author>
<author>
<name sortKey="Masters, Paul S" sort="Masters, Paul S" uniqKey="Masters P" first="Paul S" last="Masters">Paul S. Masters</name>
</author>
</analytic>
<series>
<title level="j">Journal of virology</title>
<idno type="ISSN">0022-538X</idno>
<imprint>
<date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Base Sequence</term>
<term>Cell Line</term>
<term>Cysteine (chemistry)</term>
<term>DNA, Viral (genetics)</term>
<term>Genes, Reporter</term>
<term>Membrane Fusion</term>
<term>Membrane Glycoproteins (chemistry)</term>
<term>Membrane Glycoproteins (genetics)</term>
<term>Mice</term>
<term>Molecular Sequence Data</term>
<term>Murine hepatitis virus (genetics)</term>
<term>Murine hepatitis virus (pathogenicity)</term>
<term>Murine hepatitis virus (physiology)</term>
<term>Protein Structure, Tertiary</term>
<term>Recombination, Genetic</term>
<term>Sequence Deletion</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Viral Envelope Proteins (chemistry)</term>
<term>Viral Envelope Proteins (genetics)</term>
<term>Virus Assembly (genetics)</term>
<term>Virus Assembly (physiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Cysteine</term>
<term>Membrane Glycoproteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>DNA, Viral</term>
<term>Membrane Glycoproteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Murine hepatitis virus</term>
<term>Virus Assembly</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en">
<term>Murine hepatitis virus</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Murine hepatitis virus</term>
<term>Virus Assembly</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Base Sequence</term>
<term>Cell Line</term>
<term>Genes, Reporter</term>
<term>Membrane Fusion</term>
<term>Mice</term>
<term>Molecular Sequence Data</term>
<term>Protein Structure, Tertiary</term>
<term>Recombination, Genetic</term>
<term>Sequence Deletion</term>
<term>Spike Glycoprotein, Coronavirus</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The coronavirus spike protein (S) forms the distinctive virion surface structures that are characteristic of this viral family, appearing in negatively stained electron microscopy as stems capped with spherical bulbs. These structures are essential for the initiation of infection through attachment of the virus to cellular receptors followed by fusion to host cell membranes. The S protein can also mediate the formation of syncytia in infected cells. The S protein is a type I transmembrane protein that is very large compared to other viral fusion proteins, and all except a short carboxy-terminal segment of the S molecule constitutes the ectodomain. For the prototype coronavirus mouse hepatitis virus (MHV), it has previously been established that S protein assembly into virions is specified by the carboxy-terminal segment, which comprises the transmembrane domain and the endodomain. We have genetically dissected these domains in the MHV S protein to localize the determinants of S incorporation into virions. Our results establish that assembly competence maps to the endodomain of S, which was shown to be sufficient to target a heterologous integral membrane protein for incorporation into MHV virions. In particular, mutational analysis indicated a major role for the charge-rich carboxy-terminal region of the endodomain. Additionally, we found that the adjacent cysteine-rich region of the endodomain is critical for fusion of infected cells, confirming results previously obtained with S protein expression systems.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">15331724</PMID>
<DateCompleted>
<Year>2004</Year>
<Month>09</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0022-538X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>78</Volume>
<Issue>18</Issue>
<PubDate>
<Year>2004</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Genetic analysis of determinants for spike glycoprotein assembly into murine coronavirus virions: distinct roles for charge-rich and cysteine-rich regions of the endodomain.</ArticleTitle>
<Pagination>
<MedlinePgn>9904-17</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The coronavirus spike protein (S) forms the distinctive virion surface structures that are characteristic of this viral family, appearing in negatively stained electron microscopy as stems capped with spherical bulbs. These structures are essential for the initiation of infection through attachment of the virus to cellular receptors followed by fusion to host cell membranes. The S protein can also mediate the formation of syncytia in infected cells. The S protein is a type I transmembrane protein that is very large compared to other viral fusion proteins, and all except a short carboxy-terminal segment of the S molecule constitutes the ectodomain. For the prototype coronavirus mouse hepatitis virus (MHV), it has previously been established that S protein assembly into virions is specified by the carboxy-terminal segment, which comprises the transmembrane domain and the endodomain. We have genetically dissected these domains in the MHV S protein to localize the determinants of S incorporation into virions. Our results establish that assembly competence maps to the endodomain of S, which was shown to be sufficient to target a heterologous integral membrane protein for incorporation into MHV virions. In particular, mutational analysis indicated a major role for the charge-rich carboxy-terminal region of the endodomain. Additionally, we found that the adjacent cysteine-rich region of the endodomain is critical for fusion of infected cells, confirming results previously obtained with S protein expression systems.</AbstractText>
<CopyrightInformation>Copyright 2004 American Society for Microbiology</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ye</LastName>
<ForeName>Rong</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Wadsworth Center, New York State Department of Health, New Scotland Ave., P.O. Box 22002, Albany, NY 12201-2002, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Montalto-Morrison</LastName>
<ForeName>Cynthia</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Masters</LastName>
<ForeName>Paul S</ForeName>
<Initials>PS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 AI039544</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AI045695</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>AI 39544</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>AI 45695</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C578553">MHV surface projection glycoprotein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C578557">spike glycoprotein, SARS-CoV</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>K848JZ4886</RegistryNumber>
<NameOfSubstance UI="D003545">Cysteine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003545" MajorTopicYN="N">Cysteine</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017930" MajorTopicYN="N">Genes, Reporter</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008561" MajorTopicYN="N">Membrane Fusion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006517" MajorTopicYN="N">Murine hepatitis virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011995" MajorTopicYN="N">Recombination, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017384" MajorTopicYN="N">Sequence Deletion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019065" MajorTopicYN="N">Virus Assembly</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2004</Year>
<Month>8</Month>
<Day>28</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2004</Year>
<Month>9</Month>
<Day>29</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2004</Year>
<Month>8</Month>
<Day>28</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">15331724</ArticleId>
<ArticleId IdType="doi">10.1128/JVI.78.18.9904-9917.2004</ArticleId>
<ArticleId IdType="pii">78/18/9904</ArticleId>
<ArticleId IdType="pmc">PMC514984</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Cell Biol. 1995 Oct;131(2):339-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7593163</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2003 Nov;77(21):11312-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14557617</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 1996 Apr 15;15(8):2020-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8617249</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1996 Apr 1;218(1):52-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8615041</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol Methods. 1996 Jun 14;193(1):17-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8690927</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Jan;78(2):669-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14694098</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1980 Jan;33(1):449-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6245243</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1981 Dec;115(2):334-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7314449</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1981 Nov;40(2):350-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6275093</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1985 Dec;56(3):904-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2999443</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1987 Dec;161(2):479-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2825419</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1988 Oct;166(2):415-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2845655</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1990 Oct;64(10):4784-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2168966</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1991 Apr;65(4):1916-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1848311</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1998 May 10;244(2):483-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9601516</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1998 Oct;72(10):7885-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9733825</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1998 Nov;72(11):8636-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9765403</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1999 Sep;73(9):7441-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10438834</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1999 Sep;73(9):7752-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10438865</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1997 Jan 6;227(1):215-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9007076</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1997 Jul;71(7):5148-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9188582</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1997 Dec;71(12):9278-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9371586</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2000 Feb;74(3):1393-406</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10627550</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2000 Feb;74(3):1566-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10627571</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2000 Mar 30;269(1):212-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10725213</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2000 Jun;74(11):4967-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10799570</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2001 Feb;75(3):1312-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11152504</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2001 Oct;75(19):9059-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11533169</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2001 Oct;75(20):9741-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11559807</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2002 Feb;76(3):1422-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11773416</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2002 May;76(10):4987-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11967315</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 2002 May 1;21(9):2076-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11980704</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2002 Apr 25;296(1):177-89</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12036329</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2002 Nov;76(22):11518-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12388713</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurovirol. 2002 Oct;8(5):381-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12402164</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2002 Dec;76(24):12491-502</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12438575</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2003 Apr;77(8):4528-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12663759</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2003 Apr;77(8):4597-608</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12663766</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2003 Aug;77(16):8801-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12885899</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2003 Jul 20;312(1):25-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12890618</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2003 Oct;77(19):10260-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12970410</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1995 Dec 20;214(2):453-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8553547</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B97 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002B97 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:15331724
   |texte=   Genetic analysis of determinants for spike glycoprotein assembly into murine coronavirus virions: distinct roles for charge-rich and cysteine-rich regions of the endodomain.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:15331724" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021